Literature DB >> 17383899

Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo.

Debasish Banerjee1, Balazs Hegedus, David H Gutmann, Joel R Garbow.   

Abstract

One of the major limitations to preclinical mouse therapeutic evaluation is the inherent difficulty in imaging small tumors in vivo. We present a rapid and reliable method to detect optic glioma (OPG) in a mouse neurofibromatosis-1 model (Nf1(flox/mut)GFAP-Cre mice) in vivo using Manganese-Enhanced Magnetic Resonance Imaging (MEMRI). In a blinded study, 23 mice were chosen randomly from a cohort of Nf1(flox/mut)GFAP-Cre mice and two sets of age-matched controls. In all cases, OPG presence or absence was correctly identified. In addition, the OPG size and shape were accurately measured in vivo, facilitating the use of this model for preclinical drug studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383899      PMCID: PMC2735870          DOI: 10.1016/j.neuroimage.2007.02.019

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  15 in total

1.  In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI.

Authors:  Ichio Aoki; Yi-Jen Lin Wu; Afonso C Silva; Ronald M Lynch; Alan P Koretsky
Journal:  Neuroimage       Date:  2004-07       Impact factor: 6.556

Review 2.  Intracranial neoplasms in children with neurofibromatosis 1.

Authors:  Tena Rosser; Roger J Packer
Journal:  J Child Neurol       Date:  2002-08       Impact factor: 1.987

3.  High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model.

Authors:  Qingxia Wei; Laura Clarke; Danielle K Scheidenhelm; Baoping Qian; Amanda Tong; Nesrin Sabha; Zia Karim; Nicholas A Bock; Robert Reti; Rolf Swoboda; Enkhtsetseg Purev; Jean-Francois Lavoie; M Livia Bajenaru; Patrick Shannon; Dorothee Herlyn; David Kaplan; R Mark Henkelman; David H Gutmann; Abhijit Guha
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

4.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

Review 5.  Late-onset optic pathway tumors in children with neurofibromatosis 1.

Authors:  R Listernick; R E Ferner; L Piersall; S Sharif; D H Gutmann; J Charrow
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

6.  Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history.

Authors:  R Listernick; C Darling; M Greenwald; L Strauss; J Charrow
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

7.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

Authors:  R Listernick; J Charrow; M Greenwald; M Mets
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

Review 8.  Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.

Authors:  Sureka Thiagalingam; Maree Flaherty; Frank Billson; Kathryn North
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

9.  In vivo trans-synaptic tract tracing from the murine striatum and amygdala utilizing manganese enhanced MRI (MEMRI).

Authors:  Robia G Pautler; Raymond Mongeau; Russell E Jacobs
Journal:  Magn Reson Med       Date:  2003-07       Impact factor: 4.668

10.  Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.

Authors:  M Livia Bajenaru; M Rosario Hernandez; Arie Perry; Yuan Zhu; Luis F Parada; Joel R Garbow; David H Gutmann
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

View more
  15 in total

1.  Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging.

Authors:  M Xie; Q Wang; T-H Wu; S-K Song; S-W Sun
Journal:  Neuroscience       Date:  2011-09-25       Impact factor: 3.590

2.  CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.

Authors:  Tao Sun; Scott M Gianino; Erin Jackson; David Piwnica-Worms; David H Gutmann; Joshua B Rubin
Journal:  J Neuroimmunol       Date:  2010-07-27       Impact factor: 3.478

3.  Transcranial manganese delivery for neuronal tract tracing using MEMRI.

Authors:  Tatjana Atanasijevic; Nadia Bouraoud; Dorian B McGavern; Alan P Koretsky
Journal:  Neuroimage       Date:  2017-05-13       Impact factor: 6.556

4.  Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.

Authors:  Joseph A Toonen; Yu Ma; David H Gutmann
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

5.  Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.

Authors:  Nicole M Warrington; Scott M Gianino; Erin Jackson; Patricia Goldhoff; Joel R Garbow; David Piwnica-Worms; David H Gutmann; Joshua B Rubin
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

6.  Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.

Authors:  K Y Kim; W K Ju; B Hegedus; D H Gutmann; M H Ellisman
Journal:  Neuroscience       Date:  2010-06-23       Impact factor: 3.590

Review 7.  Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma.

Authors:  David H Gutmann
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

8.  A novel murine model for localized radiation necrosis and its characterization using advanced magnetic resonance imaging.

Authors:  Sarah C Jost; Andrew Hope; Erich Kiehl; Arie Perry; Sarah Travers; Joel R Garbow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-01       Impact factor: 7.038

9.  Rethinking brain tumors: the fourth Mouse Models of Human Cancers Consortium nervous system tumors workshop.

Authors:  Karlyne M Reilly; Joshua B Rubin; Richard J Gilbertson; Joel R Garbow; Martine F Roussel; David H Gutmann
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

Review 10.  Optic Pathway Gliomas in Neurofibromatosis Type 1.

Authors:  Cynthia J Campen; David H Gutmann
Journal:  J Child Neurol       Date:  2018-01       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.